AUGMENTED IMMUNITY
associated with 49 other trademarks
Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placent...

Words that describe this trademark:

blood stem cells  stem cells umbilical  medical clinical  biological preparations  clinical blood  umbilical cords  preparations  cells  intended 

Serial Number:

87863059

Mark:

AUGMENTED IMMUNITY

Status:

Abandoned-No Statement of Use filed

Status Date:

04-25-2022

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological preparations for medical use for the treatment of cancer and other diseases, namely, auto-immune diseases, inflammatory diseases, Crohn's Disease and Multiple Myeloma; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; cells and biological tissue intended for hair restoration, namely, cells and biological preparations derived from blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease associated antigen

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

01-22-2019

Mark Drawing Status:

Standart Character Mark

Abandon Date:

04-25-2022

Business Name:

COZEN O'CONNOR, P.C.

Correspondent Name:

Recent Trademark filings by this company